Quality of Evidence
Level Description
A Multiple randomized controlled clinical trials or meta-analyses
B Single randomized trial or nonrandomized studies
C Consensus opinion of experts, case studies or standard-of-care
Disclaimer
is Guideline attempts to define principles of practice that should produce high-quality patient care.
It is applicable to specialists, primary care, and providers at all levels. is Guideline should not be
considered exclusive of other methods of care reasonably directed at obtaining the same results. e
ultimate judgment concerning the propriety of any course of conduct must be made by the clinician aer
consideration of each individual patient situation.
Neither IGC, the medical association, nor the authors endorse any product or service associated with
the distributor of this clinical reference tool.
Abbreviations
ACTH, adrenocorticotropic hormone; EMA, European Medicines Agency; EULAR, European
League Against Rheumatism; IL, interleukin; IM, intramuscular; IU, international unit; NPO,
nothing by mouth; NSAID, non-steroidal anti-inflammatory drug ; ULT, urate-lowering therapy
Source
Khanna D, Khanna PP, FitzGerald JD et al. 2012 American College of Rheumatolog y
Guidelines for Management of Gout. Part 2: erapy and Antiinflammatory Prophylaxis of
Acute Gouty Arthritis. Arthritis Care & Research. 2012;64(10):1447–1461.
106 Commerce Street, Suite 105
Lake Mary, FL 32746
TEL: 407.878.7606 • FAX: 407.878.7611
Order additional copies at GuidelineCentral.com
Copyright © 2016 All rights reserved
ACRACU16013b
